Detalhe da pesquisa
1.
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study.
Cancer Immunol Immunother
; 73(7): 126, 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733406
2.
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma.
Liver Int
; 44(1): 113-124, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789669
3.
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
Hepatol Res
; 54(4): 382-391, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37983642
4.
Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach.
Surg Endosc
; 38(2): 757-768, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052887
5.
The Prognostic Value of Preoperative Serum Markers and Risk Classification in Patients with Hepatocellular Carcinoma.
Ann Surg Oncol
; 30(5): 2807-2815, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36641514
6.
Response Prediction Model of Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Retrospective Study.
Oncology
; 101(9): 565-574, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276856
7.
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Oncology
; 101(4): 270-282, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455517
8.
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.
Oncology
; 101(10): 624-633, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307798
9.
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.
Oncology
; 101(9): 542-552, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552968
10.
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
Hepatol Res
; 53(8): 737-748, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020416
11.
Geriatric nutritional risk index as an easy-to-use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Hepatol Res
; 53(10): 1031-1042, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306040
12.
Impact of first-line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
J Gastroenterol Hepatol
; 38(8): 1389-1397, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37231943
13.
The Impact of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with Major Vascular Invasion.
Cancer Invest
; 40(1): 81-89, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34236269
14.
Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.
Oncology
; 100(12): 645-654, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103846
15.
Role of Substance P-Dependent Chemotactic Signaling in Postoperative Adhesion Formation.
J Surg Res
; 270: 49-57, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638093
16.
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child-Pugh class A or B liver function in real-world clinical practice.
Hepatol Res
; 52(9): 773-783, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35633504
17.
Dorsal vs ventral approach to the middle hepatic vein during laparoscopic left hemihepatectomy: multicenter retrospective observational study.
Surg Endosc
; 36(9): 6464-6472, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35024938
18.
Prospective Study to Evaluate the Safety and Efficacy of a New Surgical Tube Fixation Method: A Pilot Study.
World J Surg
; 46(3): 542-549, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773134
19.
Treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure.
Langenbecks Arch Surg
; 407(2): 699-706, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741671
20.
Bile Duct Stones Predict a Requirement for Cholecystectomy in Older Patients.
World J Surg
; 44(3): 721-729, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654201